Importance Tumor-treating fields (TTFields) is an antimitotic treatment modality that
interferes with glioblastoma cell division and organelle assembly by delivering low-intensity …

Important advances have been made in the understanding and management of adult gliomas
and primary CNS lymphomas—the two most common primary brain tumours. Progress in …

Importance Glioblastoma is the most devastating primary malignancy of the central nervous
system in adults. Most patients die within 1 to 2 years of diagnosis. Tumor-treating fields (…

Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive
molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has been …

Simple Summary Glioblastoma is the most common and aggressive malignant primary brain
cancer in adults. The prognosis remains poor following standard-of-care treatment with …

… Paris, Ahmed Idbaih, Soufiane El Hallani, Blandine Boisselier Data analysis and interpretation:
Marc Sanson, Yannick Marie, Ahmed Idbaih, Julien Laffaire, François Ducray, Soufiane El …

Background Rindopepimut (also known as CDX-110), a vaccine targeting the EGFR deletion
mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet …

To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide
association studies by genotyping 550K tagging SNPs in a total of 1,878 cases and 3,670 controls…

Background Bevacizumab is approved for the treatment of patients with progressive glioblastoma
on the basis of uncontrolled data. Data from a phase 2 trial suggested that the addition …

A high tumour mutational burden (hypermutation) is observed in some gliomas 1 , 2 , 3 , 4 –
5 ; however, the mechanisms by which hypermutation develops and whether it predicts the …